Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
532488 | BSE
-52.00
-1.39%
Other
Other
31/03/2023
08/12/2023
3,681.35
3,703.60
3,744.90
3,663.00
Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates for in the United States Asia Europe and internationally. The company also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids as well as markets vitamins to nutritional pharma food/beverage and feed industries. In addition it exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was founded in 1990 and is headquartered in Hyderabad India.
View LessLow 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Operating Margin (> 25%)
Strong Revenue Growth (> 10%)
Price Below SMA10D
Midcap (2B - 10B USD)
Weak P/E, and PEG ratio indicator
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
17.9%1 month
15.6%3 months
19.6%6 months
21.6%51.80
0
10.95
0.13
0.12
35.30
14.48
0
23.95B
795.68B
9.54B
0.95
34.87
45.60
21.00
22.84
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
172.25
Range1M
363.70
Range3M
557.40
Rel. volume
0.75
Price X volume
23.26M